Yonghua Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Miracor Medicalmiracormedical.cominSep 2020
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients.
HealthtechMedical Devices
Co-investorsDelta PartnersMing capitalBek VenturesQuest for GrowthSHS Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



